Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life

American Journal of Clinical Nutrition

Volumn 68, Issue 6 SUPPL., 1998, Pages

  Setchell, Kenneth D R ^a   Zimmer Nechemias, Linda ^a   Cai, Jinnan ^a   Heubi, James E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Estrogens; Genistein; Infants; Isoflavones; Phytoestrogens; Soy based formula; Soymilk

Indexed keywords

EQUOL; ISOFLAVONE; PHYTOESTROGEN; SOYBEAN PROTEIN;

ARTIFICIAL MILK; BIOTRANSFORMATION; BREAST MILK; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN METABOLISM; HUMAN; INFANT; INFANT FEEDING; SOYBEAN;

GLYCINE MAX;

EID: 0031796602     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.6.1453S     Document Type: Conference Paper

References (86)

1. National Academy of Sciences. Diet, nutrition, and cancer. Washington, DC: National Academy Press, 1982.
2. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin. In: Estrogens in the environment: influence on development. New York: Elsevier, 1985:73-106.
3. Setchell KDR, Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In: Rowland IA, ed. The role of gut microflora in toxicity and cancer. New York: Academic Press, 1988:315-45.
4. Setchell KDR. Non-steroidal estrogens of dietary origin: possible roles in health and disease, metabolism and physiological effects. Proc Nutr Soc N Z 1995;20:1-21.
5. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995;103:103-12.
6. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein and daidzein, and their β-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
7. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
8. Franke AA, Custer LJ, Cerna CM, Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 1995;208:18-26.
9. Walter ED. Genistein (an isoflavone glucoside) and its aglucone, genistin, from soybeans. J Am Oil Chem Soc 1941;63:3273-6.
10. Akiyama T, Ishida J, Nakagawa S, et al. Genistein: a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 1987;262:5592-5.
11. Barnes S, Peterson TG. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 1995;208:103-8.
12. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569-78.
13. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;201:3-21.
14. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:272-86.
15. Peterson TG, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991;179:661-7.
16. Peterson TG, Barnes S. Isoflavones inhibit growth of human prostate cancer cell lines without inhibiting epidermal growth factor receptor auto-phosphorylation. Prostate 1993;22:335-45.
17. Barnes S, Grubbs C, Carlson J, Setchell KDR. Soybeans inhibit mammary tumor growth in models of breast cancer. In: Pariza MW, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss, 1990:239-53.
18. Murrill WB, Brown N, Zhang J-X, Manzolillo PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996;17:1451-7.
19. Lamartiniere CA, Moore JB, Holland M, Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995;208:120-3.
20. Messina M, Messina V. Increasing use of soyfoods and their potential role in cancer prevention. J Am Diet Assoc 1991;91:836-40.
21. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
22. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 1994;142:251-9.
23. Adlercreutz H, Fotsis T, Lampe J, et al. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 1993;53:5-18.
24. Coward L, Kirk M, Albin N, Barnes S. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996;247:121-42.
25. Setchell KDR. Phytoestrogens: biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68(suppl):1333S-46S.
26. Cassidy A, Bingham S, Setchell KDR. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr 1995;74:587-601.
27. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in western Australia. Aust Vet J 1946;22:2-12.
28. Leopold AS, Erwin M, Oh J, Browning B. Phytoestrogens: adverse effects on reproduction in California quail. Science 1976;191:98-9.
29. Setchell KDR, Gosselin SJ, Welsh MB, et al. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987;93:225-33.
30. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel G, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993;101:372-7.
31. Soto AM, Chung KL, Sonnenschein C. The pesticides endosulfan, toxaphene and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 1994;102:380-3.
32. Barrett J. Phytoestrogens, friends or foes? Environ Health Perspect 1996;104:478-82.
33. Irvine C, Fitzpatrick M, Robertson I, Woodhams D. The potential adverse effects of soybean phytoestrogens in infant feeding. N Z Med J 1995;108:208-9.
34. Robertson IGC. Phytoestrogens: toxicity and regulatory recommendations. Proc Nutr Soc N Z 1995;20:35-42.
35. Department of Health. Advice on soya-based infant formula. Department of Health, 1996. (Document 96/244.)
36. Setchell KDR, Welsh MB, Lim CK. HPLC analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr 1987;368:315-23.
37. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phytoestrogens from soy-based infant formula. Lancet 1997;350:23-7.
38. Cruz MLA, Wong WW, Mimouni F, et al. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-40.
39. Knight DC, Eden J, Kelly G. The phytoestrogen content of infant formulas. Med J Australia 1996;164:575 (letter).
40. Huggett AC, Pridmore S, Malnoe A, Haschke F, Offord EA. Phytoestrogens in soy-based infant formula. Lancet 1997:350:815-6.
41. Walz E. Isoflavone - a saponin glucoside in soya. Justus Liebigs Ann Chem 1931;489:118-55 (in German).
42. Eldridge AC. Determination of isoflavones in soybean flours, protein concentrates and isolates. J Agric Food Chem 1982;30:353-5.
43. Murphy PA. Phytoestrogen content of processed soybean products. Food Technol 1982;34:60-4.
44. Farmakalidis E, Murphy PA. Isolation of 6′-O-acetyldaidzein and 6′-O-acetylgenistein from toasted defatted soy flakes. J Agric Food Chem 1985;33:385-9.
45. Kudou S, Flueury Y, Welti D, et al. Malonyl isoflavone glycosides in soybean seeds (Glycine max MERRILL). Agric Biol Chem 1991;55:2227-33.
46. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 1994;42:2466-74.
47. Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins, and isoflavones related to soybean processing. J Nutr 1995;125:581S-8S.
48. Eldridge A, Kwolek WF. Soybean isoflavones: effect of environment and variety on composition. J Agric Food Chem 1983; 31:394-6.
49. Coward L, Smith M, Kirk M, Barnes S. Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 1998;68(suppl):1486S-91S.
50. Messina M. Isoflavone intakes by Japanese were overestimated. Am J Clin Nutr 1995;62:645 (letter).
51. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998:128:209-13.
52. Bannwart C, Adlercreutz H, Wahala K, et al. Identification of the phyto-estrogen 3′,7-dihydroxyisoflavan, an isomer of equol in the human urine and cow's milk. Biomed Environ Mass Spectrom 1988;17:1-6.
53. Slavin JL. Phytoestrogens in breast milk - another advantage of breast-feeding? Clin Chem 1996;42:841-2.
54. Franke AA, Custer LJ. Daidzein and genistein concentrations in human milk after soy consumption. Clin Chem 1996;42:955-64.
55. Morton MS, Leung SSF, Davies DP, Griffiths K, Evans BAJ. Determination of isoflavonoids and lignans in human breast milk from British and Chinese women by gas chromatography-mass spectrometry. Am J Clin Nutr 1998;68(suppl):1537S (abstr).
56. Axelson M, Kirk DN, Cooley G, Farrant RD, Lawson AM, Setchell KDR. The identification of the weak estrogen equol (7-hydroxy-3-(4′-hydroxyphenyl) chroman) in human urine. Biochem J 1982;201:353-7.
57. Axelson M, Sjovall J, Gustafsson B, Setchell KDR. Soya - a dietary source of the non-steroidal oestrogen equol in humans and animals. J Endocrinol 1984;102:49-56.
58. Adlercreutz H, Yamada T, Wahala K, Watanabe S. Maternal and neonatal phytoestrogens in Japanese women at birth. Steroids 1997:62;72 (abstr).
59. Sahlberg B-L, Axelson M. Identification and quantification of free and conjugated steroids in milk from lactating women. J Steroid Biochem 1986;25:379-91.
60. Mykkanen H, Tikka J, Pitkanen T, Hanninen O. Fecal bacterial enzyme activities in infants increase with age and adoption of adult-type diet. J Pediatr Gastroenterol Nutr 1997:25:312-6.
61. Lu L-JW, Broemelin LD, Marshall MV, Sadagopa Ramanujam VM. A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol Biomarkers Prev 1995;4:497-503.
62. Hutchins AM, Slavin JE, Lampe JW. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 1995;95:545-51.
63. Xu X, Wang H-J, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soy-milk isoflavone than is genistein in adult women. J Nutr 1994;124:825-32.
64. Bannwart C, Adlercreutz H, Fotsis T, Wahala K, Hase T, Brunow G. Identification of O-desmethylangolensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn Chem Lett 1984;4-5:120-5.
65. Joannou GE, Kelly GE, Reeder AY, Waring MA, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995;54:167-84.
66. Kelly GE, Joannou GE, Nelson C, Reeder AY, Waring MA. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993;223:9-22.
67. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-10.
68. Mackenzie PI, Rodbourne L, Stranks S. Steroid UDP-glucuronyl transferases. Steroid Biochem Mol Biol 1992;43:1099-105.
69. Axelson M, Setchell KDR. Conjugation of lignans in human urine. FEBS Lett 1980;122:49-53.
70. Adlercreutz H. Studies of oestrogen excretion in human bile. Acta Endocrinol Suppl (Copenh) 1962;72:1-220.
71. Sheehan D, Young M. Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rat and human. Endocrinology 1979;104:1442-6.
72. Ekins RP, Edwards P, Newman B. The role of binding proteins in hormone delivery. In: Albertini A, Ekins RP, eds. Free hormones in blood. New York: Elsevier Biomedical Press, 1982:3-44.
73. Mendel C. The free hormone hypothesis: a physiologically based mathematical model. Endocrinol Rev 1989;10:232-74.
74. Nagel SC, vom Saal F, Welshons WV. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 1998;217:300-9.
75. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996;93:5925-30.
76. Winter JSD, Hughes IA, Reyes FI, Faiman C. Pituitary-gonadal relations in infancy: 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab 1976;42:679-86.
77. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disrupters: a report of the US EPA-sponsored workshop. Environ Health Perspect 1996;104:715-39.
78. Greenwald P, Nasca PC, Burnett WS, Polan A. Prenatal stilbestrol experience in mothers of young cancer patients. Cancer 1973; 31:568-72.
79. Herbst AL, Kurman RJ, Scully RE, Poskaner DC. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med 1972;287:1259-64.
80. McLusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science 1981;211:1294-303.
81. Mori T, Nagasawa H. Toxicity of hormones in perinatal life. Boca Raton, FL: CRC Press, 1988.
82. Toran-Allerand CD. Gonadal hormones and brain development: implications for the genesis of sexual differentiation. Ann N Y Acad Sci 1984;435:101-11.
83. Whitten PL, Lewis C, Russell E, Naftolin F. Potential adverse effects of phytoestrogens. J Nutr 1995;125:771S-6S.
84. Levy JR, Faber KA, Ayyash L, Hughes CL Jr. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med 1995;208:60-6.
85. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995:4:567-71.
86. Hadfield P. Japanese swallow Western diseases. New Scientist 1995;Sept 2:5.